1. Home
  2. RSKD vs PHAR Comparison

RSKD vs PHAR Comparison

Compare RSKD & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riskified Ltd.

RSKD

Riskified Ltd.

N/A

Current Price

$7.95

Market Cap

859.6M

Sector

Technology

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$10.09

Market Cap

793.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RSKD
PHAR
Founded
2012
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
859.6M
793.4M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
RSKD
PHAR
Price
$7.95
$10.09
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$7.25
★ $34.35
AVG Volume (30 Days)
★ 2.1M
32.7K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.94
$1.92
Revenue Next Year
$11.20
$8.85
P/E Ratio
★ N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$9.62
52 Week High
$8.17
$21.34

Technical Indicators

Market Signals
Indicator
RSKD
PHAR
Relative Strength Index (RSI) 76.05 38.55
Support Level $4.37 $9.62
Resistance Level N/A $11.60
Average True Range (ATR) 0.33 0.40
MACD 0.13 -0.05
Stochastic Oscillator 90.26 7.95

Price Performance

Historical Comparison
RSKD
PHAR

About RSKD Riskified Ltd.

Riskified Ltd offers an AI-powered e-commerce risk intelligence platform that identifies the individual behind each online interaction for legitimacy, helping merchants (its customers) eliminate risk and uncertainty from their business. The company's core product, the Chargeback Guarantee, automatically approves or declines online orders with performance levels that vary in accordance with its merchants' priorities. Additionally, it offers other products that mitigate similar e-commerce risks for those same merchants, including Policy Protect, Dispute Resolve, and Account Secure. Geographically, Riskified generates maximum revenue from the United States, and the rest from other regions of the Americas, Europe, the Middle East and Africa (EMEA), and the Asia-Pacific (APAC) region.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: